Clinical trial
Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine…
NCT00265265 · National Institute on Drug Abuse (NIDA), NIH · Completed
Key facts
| NCT number | NCT00265265 |
|---|---|
| Title | Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine - 1 |
| Official title | Phase 1, Double-Blind, Placebo-Controlled Multiple Dose Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cocaine-Related Disorders |
| Intervention type | Drug |
| Interventions | Atomoxetine |
| Enrollment | 16 |
| Start date | Aug 1, 2005 |
| Primary completion | Sep 1, 2006 |
| First posted | Dec 14, 2005 |
| Last update posted | Jan 12, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: